Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Asia Pac J Clin Nutr ; 28(2): 230-237, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31192551

RESUMO

BACKGROUND AND OBJECTIVES: The optimal delivery of enteral nutrition in shock patients has an important prognostic clinical value; thus, checklists for standardizing enteral nutrition should be developed. This study examined whether the use of an enteral feeding checklist can improve enteral nutrition in shock patients. METHODS AND STUDY DESIGN: A retrospective cohort study was conducted. A multidisciplinary working group developed an enteral feeding checklist. Information on patients' demographics, checklist items, and clinical outcomes was collected. RESULTS: In total, 148 patients were included. The checklist was used for 35 patients but not for the remaining 113 patients. Patients in the checklist group received enteral nutrition earlier (2.6 vs 4.6 days, p=0.017) and had a lower mechanical ventilation rate (62.9% vs 85.0%, p=0.004). The checklist group had shorter intensive care unit stay (mean 17.3 vs 25.7 days, p=0.043). No significant differences were observed in 28- and 90- day mortality, mechanical ventilation duration, and intolerance to enteral nutrition. CONCLUSIONS: The use of an enteral feeding checklist in shock patients was associated with earlier enteral nutrition delivery and decreased intensive care unit stay.


Assuntos
Lista de Checagem/métodos , Nutrição Enteral/métodos , Choque/dietoterapia , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento
2.
Crit Care ; 23(1): 111, 2019 Apr 05.
Artigo em Inglês | MEDLINE | ID: mdl-30953553

RESUMO

BACKGROUND: Microaspiration of gastric and oropharyngeal secretions is the main mechanism of entry of bacteria into the lower respiratory tract in intubated critically ill patients. The aim of this study is to determine the impact of enteral nutrition, as compared with parenteral nutrition, on abundant microaspiration of gastric contents and oropharyngeal secretions. METHODS: Planned ancillary study of the randomized controlled multicenter NUTRIREA2 trial. Patients with shock receiving invasive mechanical ventilation were randomized to receive early enteral or parenteral nutrition. All tracheal aspirates were collected during the 48 h following randomization. Abundant microaspiration of gastric contents and oropharyngeal secretions was defined as the presence of significant levels of pepsin (> 200 ng/ml) and salivary amylase (> 1685 UI/ml) in > 30% of tracheal aspirates. RESULTS: A total of 151 patients were included (78 and 73 patients in enteral and parenteral nutrition groups, respectively), and 1074 tracheal aspirates were quantitatively analyzed for pepsin and amylase. Although vomiting rate was significantly higher (31% vs 15%, p = 0.016), constipation rate was significantly lower (6% vs 21%, p = 0.010) in patients with enteral than in patients with parenteral nutrition. No significant difference was found regarding other patient characteristics. The percentage of patients with abundant microaspiration of gastric contents was significantly lower in enteral than in parenteral nutrition groups (14% vs 36%, p = 0.004; unadjusted OR 0.80 (95% CI 0.69, 0.93), adjusted OR 0.79 (0.76, 0.94)). The percentage of patients with abundant microaspiration of oropharyngeal secretions was significantly higher in enteral than in parenteral nutrition groups (74% vs 54%, p = 0.026; unadjusted OR 1.21 (95% CI 1.03, 1.44), adjusted OR 1.23 (1.01, 1.48)). No significant difference was found in percentage of patients with ventilator-associated pneumonia between enteral (8%) and parenteral (10%) nutrition groups (HR 0.78 (0.26, 2.28)). CONCLUSIONS: Our results suggest that enteral and parenteral nutrition are associated with high rates of microaspiration, although oropharyngeal microaspiration was more common with enteral nutrition and gastric microaspiration was more common with parenteral nutrition. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03411447 . Registered 18 July 2017. Retrospectively registered.


Assuntos
Vias de Administração de Medicamentos , Terapia Nutricional/normas , Choque/dietoterapia , Idoso , Secreções Corporais , Estado Terminal/terapia , Feminino , Suco Gástrico , Humanos , Inalação/fisiologia , Unidades de Terapia Intensiva/organização & administração , Unidades de Terapia Intensiva/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Terapia Nutricional/instrumentação , Terapia Nutricional/métodos , Estudos Retrospectivos , Fatores de Tempo
4.
Med. intensiva (Madr., Ed. impr.) ; 39(1): 40-48, ene.-feb. 2015. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-134038

RESUMO

El beneficio de la nutrición enteral en el paciente crítico ha sido demostrado en varios estudios, especialmente si esta es iniciada precozmente, en las primeras 24-48h de ingreso en la Unidad de Cuidados Intensivos, y en la actualidad esta práctica es recomendada por las principales guías de práctica clínica. El inicio de nutrición enteral en el paciente crítico con inestabilidad hemodinámica es una decisión controvertida, fundamentalmente debido al potencial riesgo de isquemia intestinal asociado a su empleo. Sin embargo, existen datos procedentes de estudios animales y de estudios observacionales en humanos que permiten plantear la hipótesis sobre su efecto beneficioso y seguridad. Son necesarios ensayos clínicos de intervención que establezcan una relación causa-efecto (AU)


The benefit of enteral nutrition in critically ill patients has been demonstrated by several studies, especially when it is started early, in the first 24-48h of stay in the Intensive Care Unit, and this practice is currently advised by the main clinical guidelines. The start of enteral nutrition is controversial in patients with hemodynamic failure, since it may trigger intestinal ischemia. However, there are data from experimental studies in animals, as well as from observational studies in humans that allow for hypotheses regarding its beneficial effect and safety. Interventional clinical trials are needed to confirm these findings (AU)


Assuntos
Humanos , Nutrição Enteral/métodos , Choque/dietoterapia , Estado Terminal/terapia , Hemodinâmica , Cuidados Críticos/métodos , Segurança do Paciente
5.
Nutr. hosp ; 26(supl.2): 59-62, nov. 2011. tab
Artigo em Inglês | IBECS | ID: ibc-104843

RESUMO

The response to severe burns is characterized by hypermetabolism (the most hypermetabolic existing model of aggression) and hypercatabolism, with a high degree of destruction of the skeletal musculature. Metabolic disorders are most evident in the first two weeks after the burn, although they can be prolonged in direct relation to the complications that these patients develop. Nutritional-metabolic support is an essential part of the treatment of these patients and should be started early, preferentially through the enteral route, with parenteral nutrition as complementary support. Exact calculation of calorie-protein requirements in these patients is difficult, even when indirect calorimetry is used, due to the high loss of proteins and CO2through the skin. Specific pharmaco nutrients are indicated, with a high dose of micronutrients. The use of drugs or medications with anabolic effects is also sometimes indicated (AU)


La respuesta que se objetiva tras una agresión térmica grave se caracteriza por hipermetabolismo (es el modelo de agresión más hipermetabólica que existe) e hipercatabolismo, con una elevada destrucción de la musculatura esquelética. Los trastornos metabólicos son más evidentes en las 2 primeras semanas tras la quemadura, aunque pueden prolongarse en relación directa con las complicaciones aparecidas. El soporte nutro metabólico forma parte indiscutible del tratamiento de estos pacientes y debe ser precoz, utilizando preferentemente la vía enteral y la nutrición parenteral complementaria. Es dificultoso el cálculo exacto de los requerimientos calórico proteicos, aun empleando calorimetría indirecta, debido a las elevadas pérdidas cutáneas de proteínas y Co2. Cabe destacar la indicación de farmaconutrientes específicos, de dosis elevadas de micronutrientes y, en algunas situaciones, del empleo de medicaciones o fármacos con efectos anabólicos (AU)


Assuntos
Humanos , Choque/dietoterapia , Queimaduras/dietoterapia , Proteínas/administração & dosagem , Nutrição Parenteral/métodos , Soluções de Nutrição Parenteral/farmacologia , Estado Terminal/terapia , Apoio Nutricional/métodos , Prática Clínica Baseada em Evidências/métodos , Padrões de Prática Médica
6.
Burns ; 33(2): 179-84, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17125930

RESUMO

OBJECTIVES: To investigate the effects of dietary supplementation of l-arginine (l-Arg) on shock in severely burned patients. METHODS: This was a prospective, randomized, single blind, controlled study. Forty-seven severely burned patients due to various causes with a total burn surface area (TBSA) more than 50% each admitted in early postburn phase (within 10h postburn) were included in this study. All patients were treated by the traditional resuscitation program of our institute. After the nasogastric feeding tube was placed, they were randomly divided into three groups-(1) group A400 (n = 16): giving gastrointestinal feeding with 500 ml 5% GNS, containing l-Arg (400 mg/ kgday) at equal pace with fluid resuscitation; (2) group A200 (n = 16): giving gastrointestinal feeding with 500 ml 5% GNS containing l-Arg (200 mg/ kgday); (3) group C (n = 15): giving gastrointestinal feeding with 500 ml 5% GNS without any supplementation. The feeding started within 12h after burn and lasted for 72 h, the feeding rate was controlled by an enteral feeding pump. The following parameters were observed on days (PBD) 1-4: serum nitric oxide content (NO), mean arterial blood pressure (MAP), oxygenation index (PO2/FiO2), and arterial blood content of lactic acid (LA). Gastric mucosal blood flow was measured by laser Doppler flow-metry on PBD1 and PBD2. RESULTS: (1) Enteral feeding of l-Arg did not change MAP of severely burned patients, with no difference in MAP between the l-Arg supplemented and control groups. (2) There were significant changes of the l-Arg supplemented groups (A400 and A200), with an increased gastric mucosa blood flow, oxygenation index, and a decreased LA content in arterial blood, compared with the control group. (3) The serous NO content was significantly decreased in the A400 group on PBD2-4 (P < 0.01), and in the A200 group on PBD4 (P < 0.05) compared with the control group. CONCLUSIONS: Enteral feeding with l-arginine supplementation on early stage of burn decreases NO production to a relatively normal level and exerts beneficial effects on the resuscitation of burned shock.


Assuntos
Arginina/administração & dosagem , Queimaduras/dietoterapia , Suplementos Nutricionais , Choque/dietoterapia , Adolescente , Adulto , Pressão Sanguínea/fisiologia , Queimaduras/sangue , Queimaduras/fisiopatologia , Nutrição Enteral/métodos , Feminino , Mucosa Gástrica/irrigação sanguínea , Humanos , Ácido Láctico/metabolismo , Masculino , Pessoa de Meia-Idade , Óxido Nítrico/metabolismo , Oxigênio/sangue , Estudos Prospectivos , Ressuscitação/métodos , Choque/sangue , Choque/fisiopatologia , Método Simples-Cego
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...